Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Biosystems, EBI, SIB, PIR, Agilent Technologies, European Bioinformatics Institute

Premium

Ciphergen Biosystems, in collaboration with the American Red Cross, will commercialize Protein Equalizer beads, a technology to detect low-abundance proteins in serum samples. The technology uses a combinatorial bead library to concentrate low-abundance proteins and dilute high-abundance proteins.


The EBI, SIB, and PIR have released UniProt 2.0. The database, updated biweekly, contains 1,487,788 entries and can be accessed online at www.uniprot.org. A description of changes made to Uniprot since release 1.0 can be found at http://expasy.org/sprot/relnotes/.


Agilent Technologies has introduced the Multiple Affinity Removal Column, an immunoaffinity HPLC column to remove high-abundance proteins from mouse blood serum. The column removes albumin, immunoglobulin G and transferrin, the three most common proteins found in mouse serum.


The European Bioinformatics Institute has launched Integr8, a browser that assembles information from 179 completely sequenced genomes and their predicted proteomes, which was previously dispersed. Integr8 is available at www.ebi.ac.uk/integr8.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.